HOOKIPA Pharma Ownership | Who Owns HOOKIPA Pharma?
HOOKIPA Pharma Ownership Summary
HOOKIPA Pharma is owned by 34.19% institutional investors, 19.27% insiders, and 46.54% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 6.48% of HOOK shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.83% of its assets in HOOKIPA Pharma shares.
HOOK Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | HOOKIPA Pharma | 34.19% | 19.27% | 46.54% |
| Sector | Healthcare Stocks | 492.67% | 11.09% | -403.76% |
| Industry | Biotech Stocks | 295.31% | 11.22% | -206.53% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Baker bros. advisors lp | 812.81K | 6.48% | $1.02M |
| Jbf capital | 320.98K | 2.56% | $347.00K |
| Ikarian capital | 53.00K | 0.42% | $66.51K |
| Acadian asset management | 28.02K | 0.22% | $25.00K |
| Boothbay fund management | 11.69K | 0.09% | $14.67K |
| Engineers gate manager lp | - | - | - |
| Ecor1 capital | - | - | - |
| Parallel advisors | - | - | - |
| Renaissance | - | - | - |
| Truvestments capital | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Jbf capital | 320.98K | 0.05% | $347.00K |
| Ikarian capital | 53.00K | 0.01% | $66.51K |
| Baker bros. advisors lp | 812.81K | 0.01% | $1.02M |
| Boothbay fund management | 11.69K | 0.00% | $14.67K |
| Ecor1 capital | - | - | - |
| Engineers gate manager lp | - | - | - |
| Parallel advisors | - | - | - |
| Renaissance | - | - | - |
| Truvestments capital | - | - | - |
| Advisor group | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jbf capital | 320.98K | 0.05% | 320.98K |
| Ikarian capital | 53.00K | 0.01% | - |
| Baker bros. advisors lp | 812.81K | 0.01% | - |
| Boothbay fund management | 11.69K | 0.00% | - |
| Truvestments capital | - | - | -2.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Gilead sciences | - | - | -1.88M |
| Siren | - | - | -566.64K |
| Ecor1 capital | - | - | -388.86K |
| Fmr | - | - | -334.03K |
| Vanguard group | - | - | -300.82K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Jbf capital | 320.98K | 0.05% | 320.98K | $347.00K |
Sold Out
| Holder | Change |
|---|---|
| Truvestments capital | -2.00 |
| Citigroup | -7.00 |
| Bokf, na | -8.00 |
| Sbi securities | -13.00 |
| Parallel advisors | -35.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 25 | -26.47% | 4,288,695 | -2.70% | 34 | 2.56% | 5 | -68.75% | 7 | 40.00% |
| Mar 31, 2025 | 2 | -94.74% | 865,810 | -83.76% | 6 | 0.38% | - | -100.00% | - | -100.00% |
| Dec 31, 2024 | 1 | - | 498,625 | -9.63% | 3 | 20.54% | - | - | 1 | - |
| Sep 30, 2024 | 1 | -97.62% | 551,738 | -97.97% | 4 | 0.94% | - | -100.00% | 1 | -85.71% |
| Jun 30, 2024 | 42 | -16.00% | 27,116,470 | -24.40% | 21 | 1.50% | 22 | 4.76% | 7 | 16.67% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 223.50K | 1.83% | -4.88K |
| Vanguard US Total Market Shares ETF | 140.79K | 1.17% | - |
| Fidelity VIP Growth Initial | 101.45K | 0.83% | - |
| Fidelity Capital Appreciation | 91.62K | 0.75% | - |
| Fidelity Advisor Equity Growth I | 66.86K | 0.55% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 47.98K | 0.39% | -21.86K |
| Fidelity Growth Discovery | 45.08K | 0.37% | - |
| Fidelity Extended Market Index | 38.63K | 0.32% | -272.00 |
| Dimensional US Core Equity 2 ETF | 23.95K | 0.20% | - |
| PGIM Quantitative Solutions US Micro Cap | 14.40K | 0.12% | 8.70K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 19, 2025 | Peters Malte | Chief Executive Officer | Sell | $20.68K |
| Jul 22, 2025 | Peters Malte | Chief Executive Officer | Sell | $26.84K |
| Jul 22, 2025 | Coelho Mary Theresa | EVP and CFO | Sell | $12.52K |
| Aug 21, 2023 | Kandera Reinhard | Chief Financial Officer | Buy | $5.08K |
| Aug 16, 2023 | Kandera Reinhard | Chief Financial Officer | Buy | $5.71K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 2 |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2023 Q4 | - | - |
| 2023 Q3 | 6 | - |
HOOK Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools